- Home
- CRMD vs PHK Comparison
CRMD vs PHK Comparison
Compare CRMD & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.18
Company Overview
Basic Information| Metric | CRMD | PHK |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 590.7M | 852.2M |
| IPO Year | 2009 | 2003 |
Fundamental Metrics
Financial Performance| Metric | CRMD | PHK |
|---|---|---|
| Price | $8.18 | $4.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.83 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 695.2K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.61% |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $311,709,000.00 | N/A |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.36 | ★ N/A |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $6.13 | $4.41 |
| 52 Week High | $13.34 | $5.00 |
Technical Indicators
Market Signals| Indicator | CRMD | PHK |
|---|---|---|
| Relative Strength Index (RSI) | 52.18 | 41.37 |
| Support Level | $8.08 | $4.48 |
| Resistance Level | $9.01 | $4.73 |
| Average True Range (ATR) | 0.26 | 0.04 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 30.66 | 31.25 |
Price Performance
Historical Comparison CRMD
PHK
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. The secondary objective of the company is to seek capital appreciation.